Skip to main content

Table 1 Schedule of enrolment, interventions and assessments

From: Efficacy of intra-articular injection of allogeneic platelet-rich plasma for knee osteoarthritis combined with hematologic blood dyscrasias with platelet dysfunction: protocol of a randomized, double-blind, placebo-controlled trial

Time point

  

Study period

Enrolment

Baseline

Injection

Post-allocation

Close-out

  

1

1 M

3 M

6 M

12 M

Enrolment

Eligibility screen

×

      

Informed consent

×

      

Allocation

 

×

     

Interventions:

Platelet rich plasma

  

×

    

Saline

  

×

    

Assessments:

Primary outcomes

       

aWOMAC score

 

×

 

×

×

×

×

Secondary outcomes

       

  bVAS

 

×

 

×

×

×

×

  Lysholm score

 

×

 

×

×

×

×

  cSF-36

 

×

 

×

×

×

×

  MRI analysis

 

×

    

×

Other measures

Drug/supplement use

 

×

 

×

×

×

×

Platelets and leukocytes counts, VEGF and TGF-β

  

×

    

Number of injections

  

×

    

Adverse events

  

×

×

×

×

×

Success of blinding

  

×

    

Descriptive measures

Weight, height, BMI, Kellgren and Lawrence grade, Age, gender, duration of symptoms

 

×

     

Injection site, Complications

  

×

    
  1. aWOMAC score, The Western Ontario and McMaster Universities Osteoarthritis Index; bVAS, visual analogue scale; cSF-36, the short-form 36 item health survey questionnaire